166 related articles for article (PubMed ID: 33199783)
1. Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus.
Khanam A; Kottilil S; Wilson E
Sci Rep; 2020 Nov; 10(1):19924. PubMed ID: 33199783
[TBL] [Abstract][Full Text] [Related]
2. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
3. Follicular helper T cell and memory B cell immunity in CHC patients.
Liu Y; Ji H; Zhao P; Yan H; Cai Y; Yu L; Hu X; Sun X; Jiang Y
J Mol Med (Berl); 2019 Mar; 97(3):397-407. PubMed ID: 30666346
[TBL] [Abstract][Full Text] [Related]
4. Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy.
Zoldan K; Ehrlich S; Killmer S; Wild K; Smits M; Russ M; Globig AM; Hofmann M; Thimme R; Boettler T
Front Immunol; 2021; 12():742061. PubMed ID: 34659236
[TBL] [Abstract][Full Text] [Related]
5. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.
Zhang M; Zhang L; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Int Immunopharmacol; 2016 May; 34():235-243. PubMed ID: 26971227
[TBL] [Abstract][Full Text] [Related]
6. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
[TBL] [Abstract][Full Text] [Related]
7. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses.
Spaan M; Kreefft K; de Graav GN; Brouwer WP; de Knegt RJ; ten Kate FJ; Baan CC; Vanwolleghem T; Janssen HL; Boonstra A
J Hepatol; 2015 Feb; 62(2):303-10. PubMed ID: 25281860
[TBL] [Abstract][Full Text] [Related]
8. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
9. Peripheral PD-1
Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
Front Immunol; 2019; 10():1470. PubMed ID: 31316516
[TBL] [Abstract][Full Text] [Related]
10. Characterizing Hepatitis C Virus-Specific CD4
Hartnell F; Esposito I; Swadling L; Brown A; Phetsouphanh C; de Lara C; Gentile C; Turner B; Dorrell L; Capone S; Folgori A; Barnes E; Klenerman P
Hepatology; 2020 Nov; 72(5):1541-1555. PubMed ID: 32012325
[TBL] [Abstract][Full Text] [Related]
11. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
12. Higher frequencies of circulating ICOS
Zhang Z; Shi Y; Yang K; Crew R; Wang H; Jiang Y
Autoimmunity; 2017 Dec; 50(8):458-467. PubMed ID: 29025273
[TBL] [Abstract][Full Text] [Related]
13. In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
Telatin V; Nicoli F; Frasson C; Menegotto N; Barbaro F; Castelli E; Erne E; Palù G; Caputo A
Front Cell Infect Microbiol; 2019; 9():190. PubMed ID: 31259160
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 Regulates T Follicular Helper Cell Function in Patients with Chronic Hepatitis C.
Zhang ZH; Jiang BC; Liu XH; Zhang MX; Li ZS; Zhu GZ
Viral Immunol; 2018; 31(6):417-425. PubMed ID: 29672235
[TBL] [Abstract][Full Text] [Related]
15. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
[TBL] [Abstract][Full Text] [Related]
17. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
[TBL] [Abstract][Full Text] [Related]
18. Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy.
Liu Y; Zhao P; Qu Z; Ayana DA; Jiang Y
Int Immunopharmacol; 2014 Sep; 22(1):98-106. PubMed ID: 24975830
[TBL] [Abstract][Full Text] [Related]
19. Di-(2-ethylhexyl) phthalate adjuvantly induces imbalanced humoral immunity in ovalbumin-sensitized BALB/c mice ascribing to T follicular helper cells hyperfunction.
Han Y; Wang X; Chen G; Xu G; Liu X; Zhu W; Hu P; Zhang Y; Zhu C; Miao J
Toxicology; 2014 Oct; 324():88-97. PubMed ID: 25093321
[TBL] [Abstract][Full Text] [Related]
20. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.
Asai Y; Chiba H; Nishikiori H; Kamekura R; Yabe H; Kondo S; Miyajima S; Shigehara K; Ichimiya S; Takahashi H
Respir Res; 2019 Nov; 20(1):244. PubMed ID: 31694639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
